心臓病学：2025年の新しいガイドライン

In 2025, significant progress has been made in the management of cardiovascular diseases. The introduction of the IMPS (Inflammatory Myopericardial Syndrome) concept has positioned cardiac MRI as a central diagnostic tool. In the management of dyslipidemia, lipoprotein (a) measurement has become a key component of cardiovascular risk assessment, while bempedoic acid is emerging as an effective treatment option for statin-intolerant patients. The Pregnancy Heart Team now provides a structured care pathway for cardiac patients before, during, and after pregnancy. Prevention plays a crucial role, supported by the growing awareness of the close link between mental health and cardiovascular health.